These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11019724)

  • 1. Inhaled nitric oxide and acute lung injury.
    Payen DM
    Clin Chest Med; 2000 Sep; 21(3):519-29, ix. PubMed ID: 11019724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In acute lung injury, inhaled nitric oxide improves ventilation-perfusion matching, pulmonary vascular mechanics, and transpulmonary vascular efficiency.
    Hillman ND; Meliones JN; Black DR; Craig DM; Cheifetz IM; Smith PK
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):593-9; discussion 599-600. PubMed ID: 7564424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
    Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
    Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide: more than a selective pulmonary vasodilator.
    Gianetti J; Bevilacqua S; De Caterina R
    Eur J Clin Invest; 2002 Aug; 32(8):628-35. PubMed ID: 12190963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are inhaled vasodilators useful in acute lung injury and acute respiratory distress syndrome?
    Siobal MS; Hess DR
    Respir Care; 2010 Feb; 55(2):144-57; discussion 157-61. PubMed ID: 20105341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome.
    Nakagawa TA; Morris A; Gomez RJ; Johnston SJ; Sharkey PT; Zaritsky AL
    J Pediatr; 1997 Jul; 131(1 Pt 1):63-9. PubMed ID: 9255193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled nitric oxide for the adult respiratory distress syndrome.
    Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
    N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of inhaled nitric oxide in oleic acid-induced acute lung injury.
    Shah NS; Nakayama DK; Jacob TD; Nishio I; Imai T; Billiar TR; Exler R; Yousem SA; Motoyama EK; Peitzman AB
    Crit Care Med; 1997 Jan; 25(1):153-8. PubMed ID: 8989192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute respiratory distress syndrome. Inhaled nitric oxide.
    Hanania NA; Pope C; Guntupalli KK
    Respir Care Clin N Am; 1998 Dec; 4(4):695-709. PubMed ID: 9881400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled nitric oxide in acute lung injury and acute respiratory distress syndrome. Inability to translate physiologic benefit to clinical outcome benefit in adult clinical trials.
    Dellinger RP
    Intensive Care Med; 1999 Sep; 25(9):881-3. PubMed ID: 10501736
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: a Cochrane Systematic Review with trial sequential analysis.
    Karam O; Gebistorf F; Wetterslev J; Afshari A
    Anaesthesia; 2017 Jan; 72(1):106-117. PubMed ID: 27762438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults.
    Afshari A; Brok J; Møller AM; Wetterslev J
    Cochrane Database Syst Rev; 2010 Jul; (7):CD002787. PubMed ID: 20614430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide: more than a selective pulmonary vasodilator.
    Quezado ZM; Eichacker PQ
    Crit Care Med; 2000 Apr; 28(4):1235-6. PubMed ID: 10809320
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.
    Ammar MA; Bauer SR; Bass SN; Sasidhar M; Mullin R; Lam SW
    Ann Pharmacother; 2015 Oct; 49(10):1105-12. PubMed ID: 26187741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome.
    Dzierba AL; Abel EE; Buckley MS; Lat I
    Pharmacotherapy; 2014 Mar; 34(3):279-90. PubMed ID: 24734313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective pulmonary vasodilation in acute respiratory distress syndrome.
    Kaisers U; Busch T; Deja M; Donaubauer B; Falke KJ
    Crit Care Med; 2003 Apr; 31(4 Suppl):S337-42. PubMed ID: 12682462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhaled nitric oxide: one modality in the treatment of ARDS].
    Carrillo-Esper R; Ramírez-Hernández JM; Gargallo-Hernández JJ; Hernández-Vásquez R; Domínguez-Rodríguez MI; Alemán-Alarcón CE; Gallegos-Rodríguez G
    Gac Med Mex; 1999; 135(4):417-21. PubMed ID: 10491897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
    Puri N; Dellinger RP
    Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhaled nitric oxide for the treatment of ARDS].
    Lohbrunner H; Deja M; Busch T; Spies CD; Rossaint R; Kaisers U
    Anaesthesist; 2004 Aug; 53(8):771-82; quiz 783-4. PubMed ID: 15257405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhaled ET(A) receptor antagonist LU-135252 acts as a selective pulmonary vasodilator.
    Deja M; Wolf S; Busch T; Petersen B; Jaghzies U; Boemke W; Kaisers U
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():21S-24S. PubMed ID: 12193047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.